Natus Medical Incorporated - Common Stock (NQ:NTUS)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 20, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Natus Medical Incorporated - Common Stock

Route 92 Medical Announces Appointment of Jonathan Kennedy as Chief Financial Officer

September 18, 2023

From Route 92 Medical, Inc.

Via GlobeNewswire

Novanta Shares Pop On Inclusion Into S&P MidCap 400 ↗

July 22, 2022

Via Benzinga

NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS

May 17, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

NATUS MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS

May 05, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Stocks That Hit 52-Week Highs On Thursday ↗

April 15, 2021

Thursday morning saw 166 companies set new 52-week highs. Interesting Highlights: The largest company by market cap to hit a new 52-week high was Microsoft (NASDAQ:...

Via Benzinga

68 Biggest Movers From Yesterday ↗

April 19, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...

Via Benzinga

Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide ↗

April 18, 2022

U.S. stocks traded higher in volatile session, with the Dow Jones gaining around 60 points toward the end of trading on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 18, 2022

Gainers Natus Medical (NASDAQ:NTUS) shares rose 28.8% to $33.55 during Monday's regular session. The current volume of 3.0 million shares is 2073.2% of Natus Medical...

Via Benzinga

Dow Moves Lower As Wall Street Gears Up For Earnings ↗

April 18, 2022

Stocks are struggling for direction midday, with investor sentiment dampening after the 10-year Treasury yield hit a more than three-year high this morning.

Via Talk Markets

Mid-Day Market Update: U.S. Stocks Turn Lower; Bank of America Earnings Top Views ↗

April 18, 2022

U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Monday.

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

April 18, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions....

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Dow Gains 100 Points ↗

April 18, 2022

U.S. stocks traded higher this morning, with the Dow Jones adding around 100 points on Monday.

Via Benzinga

NTUS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Natus Medical Incorporated Is Fair to Shareholders

April 18, 2022

From Halper Sadeh LLP

Via Business Wire

Benzinga's Daily Brief On Trending Tickers For April 18, 2022: Casa Systems, Twitter, DiDi Global, And More ↗

April 18, 2022

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 18, 2022

Gainers Natus Medical (NASDAQ:NTUS) stock rose 28.3% to $33.42 during Monday's pre-market session. The market value of their outstanding shares is at $1.1 billion....

Via Benzinga

Neurodiagnostic Focused Natus Medical Goes Private In $1.2B Deal ↗

April 18, 2022

Natus Medical Inc (NASDAQ: NTUS) will be acquired by ArchiMed, an investment firm focused exclusively on the healthcare industry, for approximately $1.2 billion.

Via Benzinga

Natus Medical: Q4 Earnings Insights ↗

February 24, 2022

Natus Medical (NASDAQ:NTUS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 07, 2022

On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in terms of market cap to set a new 52-week low. OceanPal (...

Via Benzinga

The Daily Biotech Pulse: Illunina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In ↗

January 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus BioAtla, Bristol-Myers Squibb Announce Collaboration To Evaluate ADC-Opdivo...

Via Benzinga

Natus Medical Inc (NTUS) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

NTUS earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Return on Capital Employed Overview: Natus Medical ↗

August 20, 2021

After pulling data from Benzinga Pro it seems like during Q2, Natus Medical (NASDAQ:NTUS) earned $6.01 million, a 33.05% increase from the preceding quarter. Natus Medical also...

Via Benzinga

Natus Medical Inc (NTUS) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

NTUS earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

June 17, 2021

This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries...

Via Benzinga

The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme ↗

June 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,...

Via Benzinga

Top 10 Reddit Stocks As Frenzy Hints At Life Beyond WallStreetBets ↗

June 10, 2021

Reddit stocks were mostly lower while the frenzy behind the rally in the likes of AMC and GameStop shows signs of extending beyond social-media buzz.

Via Investor's Business Daily

Natus Medical Incorporated (NTUS) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

NTUS earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs ↗

April 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split ↗

April 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.